Previous close | 50.80 |
Open | 50.80 |
Bid | 42.00 |
Ask | 45.70 |
Strike | 120.00 |
Expiry date | 2025-06-20 |
Day's range | 50.80 - 50.80 |
Contract range | N/A |
Volume | |
Open interest | 36 |
AbbVie (NYSE: ABBV) announced today that it has completed its acquisition of Landos Biopharma, Inc. (NASDAQ: LABP). With the completion of the acquisition, Landos is now part of AbbVie.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Eli Lilly's (LLY) stock hits an all-time high after announcing detailed results from a late-stage study on mirikizumab in Crohn's disease.